IP Library Granted Patent US 11,441,119
Granted Patent B2
US 11,441,119 · App. 16/490,811 · Granted Sep 13, 2022

Culture media comprising n-Acyl-X-glutamine dipeptides

Inventors: Guenter Knaup (Bruchkoebel, DE); Friedhelm Merz (Nierstein, DE)
Assignee: Evonik Operations GmbH
C12N5/0037C12N5/0682C12N2500/30C12N2500/32C12N2500/90
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,441,119
App. No.
16/490,811
Granted
Sep 13, 2022
Kind
B2
Abstract

Disclosed herein is a cell culture media containing L-glutamine from a set of N-acylated dipeptides Acyl-X-Q, and L-glutamine from a set of other glutamine-sources Qsource in a defined molar ratio R=n(Acyl-X-Q)/n(Qsource), wherein the variables X, Q, Acyl, R, n(Acyl-X-Q) and n(Qsource) are defined in the general disclosure. Processes of using the cell culture media are also described herein.

Claims (29)

1. A cell culture media, comprising

L-glutamine from a set of N-acylated dipeptides Acyl-XQ; and

L-glutamine from a set of other glutamine-sources Qsource in a defined molar ratio R=n(Acyl-X-Q)/n(Qsource),

wherein:

X is defined as an L-amino acid;

Q is defined as L-glutamine attached via an amide bond to L-amino acid X;

Acyl is defined as a C1-C7-acyl moiety attached via an amide bond to the amino-terminus of L-amino acid X;

R is defined to be in the range of 0.03 to 20;

n(Acyl-X-Q) is the total amount of substance of L-glutamine contained in the set of N-acylated dipeptides Acyl-X-Q in the culture media;

n(Qsource) is the total amount of substance of L-glutamine contained in the set of other glutamine sources Qsource in the culture media;

the constituents of the set of other L-glutamine sources Qsource are selected from the following: Free L-glutamine, dipeptides Y-Q, or mixtures thereof, wherein Y is defined as one of the 20 genetically encoded L-amino acids, wherein Q is defined as L-glutamine attached via an amide bond to L-amino acid Y, and the amide bond connecting Y and Q in dipeptide Y-Q is a regular backbone amide bond involving the carboxy terminus of amino acid Y and the amino terminus of glutamine Q; and

the cell culture media are serum free.

2. The cell culture media according to claim 1 , wherein the cell culture media are chemically defined.

3. The cell culture media according to claim 1 , wherein the only constituent of the set of other L-glutamine sources Qsource is dipeptide Y-Q, wherein Y is Alanine.

4. The cell culture media according to claim 1 , wherein the only constituent of the set of other L-glutamine sources Qsource is free L-glutamine.

5. The cell culture media according to claim 1 , wherein the total concentration of N-acylated dipeptides Acyl-X-Q is in the range of from 1 mM to 8 mM.

6. The cell culture media according to claim 1 , wherein the molar ratio R=n(Acyl-X-Q)/n(Qsource) is defined to be in the range of 0.04 to 15.67.

7. The cell culture media according to claim 1 , wherein the set of N-acylated dipeptides Acyl-X-Q is defined as follows: One or more of acetyl-A-Q, acetyl-G-Q, acetyl-NQ.

8. The cell culture media according to claim 1 , wherein the set of N-acylated dipeptides Acyl-X-Q is defined as follows: One or more of acetyl-A-Q, acetyl-G-Q.

9. The cell culture media according to claim 1 , wherein the set of N-acylated dipeptides Acyl-X-Q is defined as follows: Acetyl-A-Q.

10. The cell culture media according to claim 1 , wherein:

the cell culture media are chemically defined;

the only constituent of the set of other L-glutamine sources Qsource is dipeptide Y-Q, wherein Y is Alanine;

the molar ratio R=n(Acyl-X-Q)/n(Qsource) is defined to be in the range of 0.04 to 15.67;

the set of N-acylated dipeptides Acyl-X-Q is defined as follows: Acetyl-A-Q; and

the concentration of acetyl-A-Q is in the range of from 1 mM to 8 mM.

11. A process, comprising culturing cells with the cell culture media of claim 1 .

12. A process for manufacturing a cell culture product, the process comprising contacting cells with the cell culture medium of claim 1 .

13. The process according to claim 12 , wherein the cells contacted with the cell culture medium are Chinese hamster ovary (CHO) cells.

Assignments (3)
CHANGE OF NAME Recorded Jan 31, 2020
From: EVONIK DEGUSSA GMBH
To: EVONIK OPERATIONS GMBH
Reel/Frame 051765/0166 →
MERGER Recorded Oct 22, 2019
From: EVONIK TECHNOCHEMIE GMBH
To: EVONIK DEGUSSA GMBH
Reel/Frame 050789/0281 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 3, 2019
From: KNAUP, GUENTER; MERZ, FRIEDHELM
To: EVONIK TECHNOCHEMIE GMBH
Reel/Frame 050250/0857 →